2025-07-24 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive Co (CL) based on the provided data, formatted as requested:

## Colgate-Palmolive Co (CL) Stock Analysis

**Company Overview:** Colgate-Palmolive Co. (CL) is a global consumer products company focused on the production, distribution, and provision of household, health care, personal care, and pet nutrition products.

### 1. Performance vs. S&P 500 (VOO)

*   **CL Cumulative Return:** 14.78%
*   **VOO Cumulative Return:** 97.07%
*   **Disparity:**
    *   **Absolute:** -82.3%
    *   **Range (Max: 7.9, Min: -83.1):**
        *   **Current:** -83.1
        *   **Relative Disparity:** 0.0

**Analysis:** CL has significantly underperformed the S&P 500 (VOO) over the period. The relative disparity indicates that the current underperformance is near the worst end of its historical range.

### Alpha/Beta Analysis

| Year      | CAGR   | MDD   | Alpha  | Beta  | Cap(B) |
| :---------- | :----- | :----- | :----- | :---- | :----- |
| 2015-2017 | 13.0%  | 4.5%  | -16.0% | 0.0   | 61.0  |
| 2016-2018 | -11.0% | 65.2% | -29.0% | 0.1   | 48.1  |
| 2017-2019 | 7.0%   | 65.2% | -22.0% | 0.1   | 55.7  |
| 2018-2020 | 18.0%  | 65.2% | -2.0%  | 0.6   | 69.2  |
| 2019-2021 | 30.0%  | 58.6% | -19.0% | 0.7   | 69.0  |
| 2020-2022 | 7.0%   | 69.0% | 5.0%   | 0.7   | 63.7  |
| 2021-2023 | 6.0%   | 69.0% | -12.0% | 0.8   | 64.5  |
| 2022-2024 | 13.0%  | 69.0% | -12.0% | 0.8   | 73.5  |
| 2023-2025 | 2.0%   | 70.6% | -47.0% | 0.3   | 71.8  |

**Analysis:**

*   **Alpha:** The consistently negative Alpha values indicate that CL has generally underperformed relative to its risk (Beta). In recent periods(2020-2022), alpha turned to positive value of 5.0%.
*   **Beta:** The low Beta values suggest that CL's price is not very sensitive to market movements, which is typical for a stable consumer staples company.
*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows fluctuating growth rates over the periods, with a noticeable decline in the most recent period.
*   **MDD:** The Maximum Drawdown (MDD) indicates the potential downside risk during each period.

### 2. Recent Price Movement

*   **Current Price:** 88.7
*   **Last-market:**
    *   **Price:** 88.52
    *   **Previous Close:** 88.7
    *   **Change:** -0.2
*   **5-day Moving Average:** 87.416
*   **20-day Moving Average:** 89.562
*   **60-day Moving Average:** 90.3945

**Analysis:** The stock is currently trading below its 20-day and 60-day moving averages, suggesting a short-term downtrend. The recent small price decrease might indicate a period of consolidation or a minor pullback.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3359 (Low Risk)
*   **RSI:** 33.79 (Approaching oversold territory)
*   **PPO:** -0.34
*   **Hybrid Signal:** cash_70%_Sell 69.9% of holdings
*   **Relative Disparity Change (20-day):** 0.0 (Short-term decrease)
*   **Expected Return:** -3606.6%

**Analysis:**

*   **MRI:** The low MRI suggests a generally stable market environment for CL.
*   **RSI:** The RSI indicates that the stock might be approaching oversold conditions, potentially signaling a buying opportunity for some investors.
*   **PPO:** The negative PPO suggests that the short-term moving average is below the long-term moving average, confirming the downtrend.
*   **Hybrid Signal:** The signal suggests selling holdings and increasing cash position due to caution advised by low MRI.
*   **Relative Disparity Change:** Indicates the recent price action is trending lower.
*   **Expected Return:** The extremely negative expected return is highly unusual and suggests a potential anomaly in the model or data. It warrants further investigation and should not be taken as a literal prediction.

### 4. Recent News & Significant Events

*   **2025-07-22:** Major business developments, regulatory changes, or market events.
*   **2025-07-24:** Analyst discussions on performance, industry trends, and global economic factors.
*   **2025-07-23:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **2025-07-21:** Experts highlight risks and opportunities, advising monitoring of news and announcements.

**Analysis:** The news indicates that CL is currently experiencing volatility and is subject to market scrutiny. Investors should closely monitor news and company announcements.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
| :----------- | :--- | :-------- |
| 2025-04-25 | 0.85 | 4.91 B$   |
| 2024-10-25 | 0.9  | 5.03 B$   |
| 2024-07-26 | 0.89 | 5.06 B$   |
| 2024-04-26 | 0.83 | 5.07 B$   |
| 2025-04-25 | 0.83 | 5.07 B$   |

**Analysis:** The earnings data shows relatively stable EPS and revenue figures. There has been a slight dip in revenue in the most recent quarter.

### 6. Financial Information

| Quarter    | Revenue  | Profit Margin |
| :----------- | :--------- | :-------------- |
| 2025-03-31 | $4.91B   | 60.82%          |
| 2024-12-31 | $4.95B   | 60.30%          |
| 2024-09-30 | $5.03B   | 61.08%          |
| 2024-06-30 | $5.06B   | 60.62%          |
| 2024-03-31 | $5.07B   | 60.00%          |

| Quarter    | Equity   | ROE        |
| :----------- | :--------- | :----------- |
| 2025-03-31 | $0.36B   | 190.08%    |
| 2024-12-31 | $0.21B   | 348.58%    |
| 2024-09-30 | $0.43B   | 169.43%    |
| 2024-06-30 | $0.12B   | 594.31%    |
| 2024-03-31 | $0.23B   | 296.96%    |

**Analysis:**

*   **Revenue & Profit Margin:** Revenue shows a slight decrease in the most recent quarter, but profit margins remain consistently high, indicating strong operational efficiency.
*   **Equity & ROE:** Equity fluctuates, and the Return on Equity (ROE) is exceptionally high, suggesting efficient use of equity to generate profits. However, the fluctuating equity base might warrant further investigation.

### 7. 종합 분석 (Overall Analysis)

Colgate-Palmolive (CL) is currently facing several challenges:

*   **Underperformance:** CL has significantly underperformed the S&P 500.
*   **Downtrend:** The stock is in a short-term downtrend, trading below its 20-day and 60-day moving averages.
*   **Mixed Signals:** While the MRI indicates a low-risk environment, the RSI is approaching oversold territory, suggesting a potential buying opportunity. However, the hybrid signal suggests selling the holdings.
*   **Stable Fundamentals:** Revenue and EPS have been relatively stable, with high profit margins. However, there has been a slight decline in revenue recently.
*   **High ROE:** The company generates good profit with equity.

**Recommendation:**

Given the mixed signals and recent underperformance, a cautious approach is warranted.
* The hybrid signal suggests reducing exposure and increasing cash position, which can be a reasonable strategy.
* The extremely negative expected return is an anomaly that needs further investigation before making any investment decisions.

